Prognostic Value of LINC01140 in Colorectal Cancer and Its Regulatory Effect on Chemotherapy Resistance via miR‐942‐5p/NRXN1
- 1Department of General Surgery Xinxiang Central Hospital Xinxiang China
Abstract
Long non‐coding RNAs play a wide role in colorectal cancer (CRC). But the function of LINC01140 in CRC has not yet been revealed. This study aims to explore the functional mechanism of LINC01140 in CRC, with the expectation of providing new therapeutic targets for CRC. The histological expression of LINC01140 was examined to evaluate its clinical predictive value in CRC prognosis. The potential downstream (miR‐942‐5p/NRXN1) of LINC01140 were predicted using bioinformatics methods, and their targeted relationship was verified through RNA pull‐down and dual luciferase reporter assays. The effects of this regulatory axis on the functions of CRC cells and cancer‐associated fibroblasts (CAFs) were evaluated through CCK‐8 or Transwell experiments. Cisplatin‐ and oxaliplatin‐ tolerant CRC cell lines were established for chemotherapy resistance studies. LINC01140 exhibited significant downregulation in CRC tumor tissues and was associated with an unfavorable prognosis. The chi‐square test revealed the association between LINC01140 and TNM stage as well as lymphatic metastasis. Overexpression of LINC01140 suppressed the proliferation and migration/invasion capacities of CRC cells and alleviated their chemotherapy resistance, reducing the IC50 values of cisplatin and oxaliplatin for drug‐resistant cells. LINC01140 acted as a sponge for miR‐942‐5p and inhibited the functions of CRC cells and CAFs by upregulating NRXN1. Co‐culture with CAFs promoted the chemoresistance of CRC cells. Upregulation of LINC01140/NRXN1 or inhibition of miR‐942‐5p in CAFs attenuated this ability. LINC01140 may serve as a biomarker in CRC prognosis. It suppresses CRC cells and hinders CAF activation, alleviating chemotherapy resistance by regulating miR‐942‐5p/NRXN1.
Related
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
- PDLIM4 increases sphingolipid accumulation to promote cancer stem cell characteristics and chemotherapy resistance in colorectal cancer
- Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
- Clinical outcomes and prognostic factors of Ommaya reservoir-based intrathecal chemotherapy in lung cancer leptomeningeal metastasis: a retrospective cohort study
BibTeX
@article{zhao2026prognostic,
title = {{Prognostic Value of LINC01140 in Colorectal Cancer and Its Regulatory Effect on Chemotherapy Resistance via miR‐942‐5p/NRXN1}},
author = {Jian Zhao and Songjie Liu and Bing Xu},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
month = oct,
doi = {10.1002/jbt.71146},
url = {https://doi.org/10.1002/jbt.71146},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Prognostic Value of LINC01140 in Colorectal Cancer and Its Regulatory Effect on Chemotherapy Resistance via miR‐942‐5p/NRXN1
AU - Jian Zhao
AU - Songjie Liu
AU - Bing Xu
PY - 2026
DA - 2026/10/27
JO - Journal of Biochemical and Molecular Toxicology
DO - 10.1002/jbt.71146
UR - https://doi.org/10.1002/jbt.71146
AB - Long non‐coding RNAs play a wide role in colorectal cancer (CRC). But the function of LINC01140 in CRC has not yet been revealed. This study aims to explore the functional mechanism of LINC01140 in CRC, with the expectation of providing new therapeutic targets for CRC. The histological expression of LINC01140 was examined to evaluate its clinical predictive value in CRC prognosis. The potential downstream (miR‐942‐5p/NRXN1) of LINC01140 were predicted using bioinformatics methods, and their targeted relationship was verified through RNA pull‐down and dual luciferase reporter assays. The effects of this regulatory axis on the functions of CRC cells and cancer‐associated fibroblasts (CAFs) were evaluated through CCK‐8 or Transwell experiments. Cisplatin‐ and oxaliplatin‐ tolerant CRC cell lines were established for chemotherapy resistance studies. LINC01140 exhibited significant downregulation in CRC tumor tissues and was associated with an unfavorable prognosis. The chi‐square test revealed the association between LINC01140 and TNM stage as well as lymphatic metastasis. Overexpression of LINC01140 suppressed the proliferation and migration/invasion capacities of CRC cells and alleviated their chemotherapy resistance, reducing the IC50 values of cisplatin and oxaliplatin for drug‐resistant cells. LINC01140 acted as a sponge for miR‐942‐5p and inhibited the functions of CRC cells and CAFs by upregulating NRXN1. Co‐culture with CAFs promoted the chemoresistance of CRC cells. Upregulation of LINC01140/NRXN1 or inhibition of miR‐942‐5p in CAFs attenuated this ability. LINC01140 may serve as a biomarker in CRC prognosis. It suppresses CRC cells and hinders CAF activation, alleviating chemotherapy resistance by regulating miR‐942‐5p/NRXN1.
SN - 1095-6670
SN - 1099-0461
ER -